Summer CME Series
The University of Illinois Cancer Center is hosting its 2025 Summer CME Series at mHUB, located at 1623 W. Fulton Street, Chicago, Illinois 60612, on June 11, 18 and 25.
June 11 – Breast Cancer
Course Chair: Abiola Ibraheem, MD
Assistant Professor
Division of Hematology/Oncology
Department of Medicine
Center for Global Health
University of Illinois Cancer Center
Chicago, IL
The goal of this CME activity is to enhance participants’ knowledge and competence in the latest advancements in targeted therapies for cancer treatment. By integrating emerging evidence, optimizing therapeutic strategies, and addressing adverse event management, clinicians will be better equipped to improve patient outcomes and personalize cancer care.
June 18 – General Oncology
Course Chair: VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology
UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
The goal of this CME activity is to provide oncology professionals with the latest evidence-based updates on the diagnosis, treatment, and emerging therapies for lung and pancreatic cancers, as well as the evolving role of antibody-drug conjugates (ADCs) and management strategies for CNS metastases. This program aims to enhance clinical decision-making and optimize patient outcomes through a multidisciplinary approach.
June 25 – Hematologic Malignancies
Course Chair: Carlos Galvez, MD
University of Illinois Cancer Center
Chicago, IL
This CME activity aims to enhance clinicians’ understanding of cutting-edge treatment strategies in hematologic malignancies, including advancements in CAR T-cell therapy, novel triple-drug regimens for relapsed/refractory AML, and the evolving role of BCMA-targeted therapies and minimal residual disease (MRD) testing in multiple myeloma. By integrating the latest clinical data, participants will be better equipped to optimize patient outcomes through individualized and evidence-based treatment approaches.